Abstract Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by small benign tumors of mesenchymal origin also known as phosphaturic mesenchymal tumors mixed connective tissue variant. Excellent prognosis is expected with eradication of the culprit tumor. These small tumors are notoriously difficult to localize with conventional imaging studies; this often leads to an extensive work up and prolonged morbidity. We report a patient with clinical diagnosis of TIO whose culprit tumor was localized with Ga-68 DOTATOC PET/CT and MRI. Biopsy and cryoablation were performed under Ga-68 DOTATOC PET/CT guidance. Autoradiography of the biopsy specimen was performed and showed in situ correlation between Ga-68 DOTATOC uptake and histopathology with millimeter resolution.
Introduction
Tumor-induced osteomalacia (TIO) is a rare acquired paraneoplastic syndrome caused by overexpression of fibroblast growth factor-23 (FGF-23) which inhibits renal phosphate reabsorption causing severe osteomalacia [1] . Small benign tumors of mesenchymal origin (bones 53 %, soft tissues 45 % and skin 3 %) also known as phosphaturic mesenchymal tumor mixed connective tissue (PMTMCT) variant are the causative agents. Patients present with progressive musculoskeletal pain, fractures, and muscular weakness. The diagnosis is clinical and biochemical based on high serum FGF-23, low serum phosphorus, high fractional excretion of phosphate in the urine, normal, or low serum 1, 25 vitamin D, high alkaline phosphatase, normal calcium, and normal parathyroid hormone. Difficulty in localizing the culprit tumor and nonspecific symptoms can lead to prolonged morbidity. The small-size and low-grade nature of PMTMCT often make it difficult to localize the culprit tumor by conventional imaging studies. The proposed diagnostic methods are FDG PET/CT, whole body MRI, and In-111 pentetreotide SPECT/CT. Somatostatin tumor receptor 2A (SSTR2A) is highly expressed in PMTMCT [2] . Negative staining for both FGF-23 and SSTR2A is suggested as a definitive rule-out test for PMTMCT. Galium-68 DOTATOC is a radiolabeled DOTAconjugated peptide that together with Ga- PET/CT is emerging as an ideal diagnostic method for PMTMCT compared to FDG PET/CT and In-111 octreotide SPECT/CT due to its superior detection rate [3] . Excellent prognosis is expected with complete eradication of culprit tumor and metastasis or local recurrence are rare.
Case report
A 45-year-old female presented with a 5-year history of diffuse body pain and fractures of several bones including the right calcaneus, over 10 vertebrae, and several ribs. She was wheelchair bound for a prolonged period and ambulated with a cane at baseline. Patient did not have history of trauma or excess vitamin A use. On physical exam, she had tenderness over several bones, antalgic gait, and slight weakness of motor strength in extremities. Select relevant laboratory values were as follows: normal serum calcium (8.8 mg/dL), low serum phosphorus (0.9 mg/dL), high urine phosphorus (139.4 mg/ dL), high serum FGF-23 (279 RU/mL), low serum 1, 25 vitamin D (13 pg/mL), and normal parathyroid hormone (PTH) (8.9 mg/dL and 83.5 pg/mL). The fractional excretion of phosphate was calculated at 25 % (inappropriately high in the presence of hypophosphatemia). Diagnosis of TIO was made based on high urine phosphate excretion in the setting of low serum phosphorus, low 1, 25 vitamin D, and high serum FGF-23. Patient was treated with: high dose calcitriol 1.25 mcg orally twice daily and elemental phosphorus 250 mg three tablets every 6 h, ergocalciferol 50,000 IU once weekly, and cinacalcet 30 mg daily while investigating the location of the culprit tumor.
Plain X-rays, contrast-enhanced CT scan, radionuclide bone scan, In-111 pentetreotide scan (OctreoScan), and FDG PET/CT scan all failed to show a definite culprit tumor. The patient underwent complete dermatologic exam. A punch biopsy of a tender nodule in the left ankle revealed angiolipoma. Ga-68 DOTATOC PET/CT showed focal increased uptake in a small focus in the right anterolateral sixth rib (SUV 18.5) with no CT correlate (Fig. 1) . To further investigate, this finding MRI of the chest was performed and confirmed a small enhancing marrow lesion in the same location. Orthopedic surgical oncology advised image-guided biopsy for confirmation of diagnosis.
Intervention
An intravenous injection of 4.99 mCi Ga-68 DOTATOC was done while patient was in preoperative preparation room in the fasted state. After an approximately 46 min uptake period while general anesthesia was induced, lowdose CT and PET images of the lower chest/upper abdomen (one field of view) were acquired with a Discovery 690 PET/ CT scanner (GE Healthcare, Waukesha, WI, USA). No contrast material was administered. General anesthesia and a single prophylactic dose of intravenous Ancef to cover skin flora are given for all ablation interventions are parts of institutional standards. The lesion was localized with Ga-68 DOTATOC PET images fused with corresponding CT images. Under CT fluoroscopic guidance, a 13-gage Madison Bone Biopsy MiniKit (Laurane Medical, Le Pradet, France) was advanced into the lesion via an anterior medial approach. Imaging confirmation of proper sampling was performed by fusing CT image of needle in the bone with the preliminary PET acquisition (Fig. 2A) . A total of two core specimens were obtained while the rib was drilled through-and-through using the biopsy needle (Fig. 2) . Autoradiography was performed on the first specimen using an imaging plate (Fujifilm, BAS, MS20-25) which was scanned using a Typhoon FLA 7000 laser scanner (GE Healthcare) 20 min after the exposure. Green or blue stains were applied to each end of the biopsy specimen to help retain orientation between PET/CT biopsy image, autoradiography, and surgical pathology slides (Fig. 3) . After onsite cytopathologic confirmation of lesional specimen and confirmation of tracer activity in the specimen with autoradiography, a single Perc-17 cryo applicator (Endocare Inc., Austin, TX, USA) was advanced into the lesion through the introducer needle of the biopsy needle. The introducer needle was then retracted back over the applicator to stay a few centimeters away from the ice ball. A new PET acquisition was obtained and images were fused with the CT images of cryoprobe within the lesion (Fig. 2B) .
The total length of the procedure was 122 min. Operator doses for PET-guided ablations have previously been shown to be low for 18 F-FDG [4] . Due to the shorter half life and slightly lower gamma constant of 68 Ga compared to 18 F, as well as the lower activity utilized, a conservative estimate of the operator dose for a 68 Ga-DOTATOCguided ablation would be about 0.005 mSv effective dose and 0.010 mSv extremity dose [4, 5] .
Pneumodissection and local warm compress were used to protect the overlying skin. Two freeze cycles were performed at 100 % power for 12 and 8 min, respectively. Each freeze cycle was followed by a 6-min thaw cycle. The first thaw cycle was passive and the second cycle was active. Target temperatures of -145 and -147°C were recorded in the first and second freeze cycles, respectively.
In FDG PET/CT-guided ablations with split-dose technique, resolution of FDG avidity with the second dose at the end of ablation procedure has been shown to correlate with treatment efficacy [6] . Since split-dose technique was not used in this case, final PET images continued to show avidity within the lesion as expected. The endpoint of the procedure was determined by appropriate coverage of the 
Outcomes
The patient was discharged home the next day after an uneventful recovery. She was taken off all oral supplements at the time of discharge. Surgical pathology confirmed phosphaturic mesenchymal tumor mixed connective tissue variant. The location of tumor cells on the first specimen was concordant with findings on Ga-68 DOTATOC PET/CT images and QABS. By immunohistochemistry, the neoplastic cells did not express PAX8, cytokeratin, and CD34 (Fig. 3) . Serum FGF-23 was normal on blood work drawn the next day (82 RU/mL; normal range\180). Over the course of several days after ablation, the patient progressively felt better with complete resolution of diffuse bone pain in less than 2 weeks. All Fig. 2 A Ga-68 DOTATOC PET/CT-guided biopsy. The arrows depict the first biopsy specimen within the needle. The specimen ends were stained green (dotted arrow) and blue (solid arrow) to retain orientation between this image, autoradiography, and surgical pathology. B Ga-68 DOTATOC PET/CT-guided cryoablation. A new PET acquisition is used for this fused image. The arrows depict the markers at both ends of active tip of cryoapplicator. The ice ball properly covered the lesion and intended margin during both freeze cycles (not shown) Fig. 3 A Color photograph of biopsy specimen in an orientation close to Fig. 2A . B The end of the specimen close to the tip of needle (solid arrow on Fig. 2A) is stained blue at the bottom of this image and the other end (dotted arrow on Fig. 2A ) is stained green on top of the image. The black line depicts the two stained ends. C Autoradiography of biopsy specimen in the same orientation shows intense activity toward the end stained green. D Select images of each end of specimen show tumor cells on the end stained green and normal marrow elements on the blue stained end. The green end contains monomorphic spindle cells with no atypia or abnormal mitotic activity representing phosphaturic mesenchymal tumor mixed connective tissue variant. The findings on Ga-68 DOTATOC PET/CTguided biopsy, autoradiography, and surgical pathology are concordant biochemical abnormalities including serum phosphorus (3.4 mg/dL), alkaline phosphatase (54 U/L), and serum 1, 25 vitamin D level (70.6 pg/mL) were normal on the first available blood work drawn between 5 and 14 days after cryoablation. A GA-68 DOTATOC PET/CT was not obtained for follow-up imaging as this agent is not currently FDA approved for this indication in the United States. Contrast-enhanced CT scan and FDG PET/CT scan obtained 6 weeks after cryoablation showed a small mixed lytic-sclerotic focus in the right anterolateral sixth rib and mild non-nodular FDG avidity at the edges of ablation margin representing cryoablation effect. The tumor was deemed to be in remission.
Discussion
The most challenging factor in the management of tumorinduced osteomalacia is localizing the culprit tumor. A supplemental treatment regimen with phosphate and vitamin D is maintained while investigating the location of culprit tumor. Once the tumor is localized excellent prognosis is expected with total eradication. Surgical resection is the treatment of choice and radiation treatment is considered for unresectable tumors. A few successful imageguided ablation of PMTMCT has been reported [7, 8] . In this case, since the lesion was not visible with conventional imaging studies, confirmation of diagnosis was necessary before definitive treatment. The lesion also needed to be localized at the time of biopsy to facilitate localization at the time of surgical resection. Since image-guided biopsy was planned with a research PET agent with limited access and because of the small-size and low-grade malignant potential of these tumors which provide high success rates for ablation, it was agreed by consensus to plan for definitive ablation at the time of biopsy. CT-guided biopsy and ablation based on anatomic landmarks was unacceptable due to conspicuity of a small lesion on CT imaging in an area with very few anatomic landmarks. Due to suboptimal design of the only available MR-compatible bone biopsy needle (InVivo, Schwerin, Germany) for a nonexpansile rib and also because of inability to treat intraprocedural pneumothorax in the interventional MR suite, it was decided to perform the biopsy using Ga-68 DOTA TOC PET/CT guidance. Since image-guided ablation has been shown effective for small benign musculoskeletal tumors, it is expected for this lesion to have a reasonably good prognosis with the image-guided ablation [9] .
Quantitative autoradiography of biopsy specimens (QABS) obtained by F-18 FDG PET/CT guidance has been shown to accurately correlate with histopathologic findings [10] . Because of the established correlation between autoradiography and histopathology, autoradiography of biopsy specimen was added to standard on-site cytopathologic assessment to increase diagnostic yield of biopsy specimen prior to ablation. This justifies efforts to reduce the time needed for specimen autoradiography and to calibrate the detector response for Ga-68 in order to quantify the activity in specimens extracted under Ga-68 DOTATOC PET/CT. This case shows successful utilization of Ga-68 DOTATOC PET/CT for localization and imaging guidance for biopsy and cryoablation of an otherwise radiographically occult PMTMCT. Although surgical resection is the treatment of choice, image-guided biopsy, and ablation may be considered for select patients with tumor-induced osteomalacia.
